Exact sample-size determination in testing non-inferiority under a simple crossover trial

被引:6
作者
Lui, Kung-Jong [1 ]
Chang, Kuang-Chao [2 ]
机构
[1] San Diego State Univ, Coll Sci, Dept Math & Stat, San Diego, CA 92182 USA
[2] Fu Jen Catholic Univ, Dept Stat & Informat Sci, Taipei, Taiwan
关键词
sample-size determination; exact test procedure; power; type I error; crossover trial; non-inferiority; odds ratio; ODDS RATIO; EQUIVALENCE;
D O I
10.1002/pst.506
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
For testing the non-inferiority (or equivalence) of an experimental treatment to a standard treatment, the odds ratio (OR) of patient response rates has been recommended to measure the relative treatment efficacy. On the basis of an exact test procedure proposed elsewhere for a simple crossover design, we develop an exact sample-size calculation procedure with respect to the OR of patient response rates for a desired power of detecting non-inferiority at a given nominal type I error. We note that the sample size calculated for a desired power based on an asymptotic test procedure can be much smaller than that based on the exact test procedure under a given situation. We further discuss the advantage and disadvantage of sample-size calculation using the exact test and the asymptotic test procedures. We employ an example by studying two inhalation devices for asthmatics to illustrate the use of sample-size calculation procedure developed here. Copyright (c) 2012 John Wiley & Sons, Ltd.
引用
收藏
页码:129 / 134
页数:6
相关论文
共 44 条
  • [31] Sample Size Determination for a 3-Treatment 3-Period Crossover Trial in Frequency Data
    Kung-Jong Lui
    Therapeutic Innovation & Regulatory Science, 2018, 52 : 407 - 415
  • [33] SAMPLE-SIZE DETERMINATION UNDER AN EXPONENTIAL MODEL IN THE PRESENCE OF A CONFOUNDER AND TYPE-I CENSORING
    LUI, KJ
    CONTROLLED CLINICAL TRIALS, 1992, 13 (06): : 446 - 458
  • [34] A two-stage sample size recalculation procedure for placebo- and active-controlled non-inferiority trials
    Schwartz, Todd A.
    Denne, Jonathan S.
    STATISTICS IN MEDICINE, 2006, 25 (19) : 3396 - 3406
  • [35] Comparison of three sample size calculation methods for non-inferiority vaccine trials with multiple continuous co-primary endpoints
    Yang, Jiaying
    Li, Jingxin
    Wang, Shiyuan
    Luo, Li
    Liu, Pei
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (01) : 256 - 263
  • [36] Exact sample size determination for the ratio of two incidence rates under the Poisson distribution
    Shan, Guogen
    COMPUTATIONAL STATISTICS, 2016, 31 (04) : 1633 - 1644
  • [37] Exact sample size determination for the ratio of two incidence rates under the Poisson distribution
    Guogen Shan
    Computational Statistics, 2016, 31 : 1633 - 1644
  • [38] Non-inferiority trial of two commercial zilpaterol HCl brands in Bos indicus cattle under humid tropical conditions
    Nieto-Carmona, Agustin
    Aguilar-Acevedo, Jeny
    de la Salud Rubio, Maria
    Alvarado-Garcia, Pedro
    Tapia, Graciela
    Ocampo, Luis
    Sumano, Hector
    VETERINARIA MEXICO, 2018, 5 (02):
  • [39] Application of opioid-free general anesthesia for gynecological laparoscopic surgery under ERAS protocol: a non-inferiority randomized controlled trial
    Chen, Liang
    He, Wensheng
    Liu, Xue
    Lv, Fahui
    Li, Yuanhai
    BMC ANESTHESIOLOGY, 2023, 23 (01)
  • [40] Efficacy, safety and acceptability of the new pen needle 34G x 3.5 mm: a crossover randomized non-inferiority trial; AGO 02 study
    De Berardis, Giorgia
    Scardapane, Marco
    Lucisano, Giuseppe
    Abbruzzese, Santina
    Bossi, Antonio Carlo
    Cipponeri, Elisa
    D'Angelo, Paola
    Fontana, Lucia
    Lancione, Roberta
    Marelli, Giuseppe
    Sciangula, Luigi
    Nicolucci, Antonio
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (09) : 1699 - 1704